Financing channel feed – Endpoints News

Financing channel feed

With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases

4 years ago

Going after an old GSK target in a new way, a Yale spinout hits the clinic and nabs a modest raise

4 years ago

Selling shares at a discount, Zymeworks grabs $100M cash in hopes of turnaround

4 years ago

A new Third Rock startup seeks a 'second golden age' of GPCR drug discovery based on Nobel laureate's work

4 years ago

Biotech bears are mauling stocks as 2022 opens on a bleak note for investors

4 years ago

Digital med company Akili set to go public via Palihapitiya-backed SPAC — furthering commercial launch and pipeline expansion

4 years ago

Well-connected, Gilead-backed biotech gets another stack of cash to pursue CAR-Ts for autoimmune disease

4 years ago

Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box

4 years ago

Gen 2: Berkeley spinout lands $175M megaround to keep it on the cutting edge of the booming gene-editing field

4 years ago

Nasal sprays to stave off viruses days at a time? J&J’s newest biotech partner draws $140M for 'proactive' approach

4 years ago

Eli Casdin co-leads $250M infusion into microfluidics player that landed NIH funding for Covid-19 testing

4 years ago

F-Prime backed startup nabs another $50M in bid to scale up AI R&D software

4 years ago

Psychedelics biotech set to go public via SPAC — pushing IV form of psilocybin into PhI

4 years ago

A high-res microscope the size of a toaster? A microscopy startup earns big-name VC backers

4 years ago

Next-gen CAR-T player steps on the gas with a $111M boost and a positive glimpse at early data

4 years ago

OrbiMed takes point on a new biotech launch, but almost everything remains secret for now

4 years ago

A George Church spinout fighting the viral vector bottleneck in cell and gene therapy lands $55M

4 years ago

A new startup wants to take antisense and siRNA one step further, and build more potent drugs than Ionis and Alnylam

4 years ago

British billionaire Mike Platt hops on board a London startup looking at drug discovery from a different angle

4 years ago

With its lead CAR-T flashing some PhI data, Arcellx readies a jump to Nasdaq

4 years ago

Billionaires Chamath Palihapitiya and Pablo Legorreta hatch an $825M SPAC for cell therapy biotech

4 years ago

Vigil Neuroscience hits Wall Street with two ex-Amgen TREM2 agonists

4 years ago

Bob Nelsen, Anne Wojcicki join $20M round for longevity startup hoping to slow down aging of the ovary

4 years ago

Low-profile Shanghai-based CDMO secures high profile investors for 9-digit Series C

4 years ago

First page Previous page 59 60 616263 64 65 Next page Last page